Intrathecal dexamethasone for pediatric influenza-associated acute necrotizing encephalitis
- PMID: 40855370
- DOI: 10.1007/s10072-025-08402-5
Intrathecal dexamethasone for pediatric influenza-associated acute necrotizing encephalitis
Conflict of interest statement
Declarations. Conflict of interest: On behalf of all authors, the corresponding author states that there is no conflict of interest.
References
-
- Sakuma H, Thomas T, Debinski C et al (2025) International consensus definitions for infection-triggered encephalopathy syndromes. Dev Med Child Neurol 67:195–207. https://doi.org/10.1111/dmcn.16067 - DOI - PubMed
-
- Qin N, Wang J, Peng X, Wang L (2023) Pathogenesis and management of acute necrotizing encephalopathy. Expert Rev Neurother 23:641–650. https://doi.org/10.1080/14737175.2023.2224503 - DOI - PubMed
-
- Takanashi J-I, Uetani H (2023) Neuroimaging in acute infection-triggered encephalopathy syndromes. Front Neurosci 17:1235364. https://doi.org/10.3389/fnins.2023.1235364 - DOI - PubMed - PMC
-
- D’Eleuterio A, Rufini P, L’Erario M et al (2024) Management of critically ill children with acute necrotizing encephalitis during an H1N1 outbreak in a tertiary pediatric hospital: A series of three cases and literature review. Neuropediatrics. https://doi.org/10.1055/a-2442-5810 - DOI - PubMed
-
- Fisher KS, Muscal E, Lai YC et al (2025) Implementation of an institutional protocol for the use of intrathecal dexamethasone for treatment-refractory pediatric neuroinflammatory disease. Pediatr Neurol 168:1–5. https://doi.org/10.1016/j.pediatrneurol.2025.04.005 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources